Cellectar Biosciences (CLRB) Proxy filing summary

Executive summary

• Annual Meeting scheduled for July 7, 2026, to be held virtually for all stockholders of record as of May 19, 2026.

• Proxy materials, including Notice, Proxy Statement, and Annual Report, are available online, with options for paper or email copies upon request.

• Stockholders can vote online before or during the meeting using a unique 11-digit Control Number.

Voting matters and shareholder proposals

• Election of two Class III directors: Andrew Gu and Douglas J. Swirsky.

• Proposal to increase shares available under the 2021 Stock Incentive Plan.

• Ratification of Deloitte & Touche, LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote on named executive officer compensation.

• Approval of warrant exercise for up to 39,618,078 shares of common stock under Nasdaq rules.

• Approval to adjourn the meeting if more time is needed to solicit votes for the warrant exercise proposal.

Board of directors and corporate governance

• Board recommends voting "FOR" all director nominees and all proposals on the agenda.